NDC Pharmacologic Class N0000193543 Vascular Endothelial Growth Factor Inhibitor [EPC]
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0024-5840 | Zaltrap | Ziv-aflibercept | Solution, Concentrate | Intravenous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0024-5841 | Zaltrap | Ziv-aflibercept | Solution, Concentrate | Intravenous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0069-0315 | Zirabev | Bevacizumab-bvzr | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-0342 | Zirabev | Bevacizumab-bvzr | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
50242-060 | Avastin | Bevacizumab | Injection, Solution | Intravenous | Genentech, Inc. | Human Prescription Drug |
50242-061 | Avastin | Bevacizumab | Injection, Solution | Intravenous | Genentech, Inc. | Human Prescription Drug |
50242-080 | Lucentis | Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | Human Prescription Drug |
50242-082 | Lucentis | Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | Human Prescription Drug |
55513-206 | Mvasi | Bevacizumab-awwb | Injection, Solution | Intravenous | Amgen Inc | Human Prescription Drug |
55513-207 | Mvasi | Bevacizumab-awwb | Injection, Solution | Intravenous | Amgen Inc | Human Prescription Drug |
61755-005 | Eylea | Aflibercept | Injection, Solution | Intravitreal | Regeneron Pharmaceuticals, Inc. | Human Prescription Drug |
There are 11 NDC products with the pharmacologic class Vascular Endothelial Growth Factor Inhibitor [EPC].